Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiol Young ; 31(5): 865-866, 2021 May.
Article in English | MEDLINE | ID: mdl-33568249

ABSTRACT

Kawasaki disease is an acute systemic vascular disease, generally self-limited and typically affecting children <5 years old, which leads to coronary artery aneurysms in about 25% of untreated cases. Cardiovascular involvement is characterised by transient pancarditis, in acute phase, while coronary illness, ranging from mild dilation to giant CAAs occurs late, rarely before the 10th day since fever onset. Here, we describe a peculiar case of KD, which occurred in a 4-month-old infant and presented with exudate cardiac tamponade and early giant aneurism of both the proximal right coronary artery) and the left circumflex coronary artery, in acute phase of the disease.


Subject(s)
Cardiac Tamponade , Coronary Aneurysm , Mucocutaneous Lymph Node Syndrome , Cardiac Tamponade/diagnosis , Cardiac Tamponade/etiology , Child , Child, Preschool , Coronary Aneurysm/diagnosis , Coronary Aneurysm/diagnostic imaging , Coronary Vessels/diagnostic imaging , Humans , Infant , Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/diagnosis
2.
Acta Myol ; 40(4): 184-186, 2021 Dec.
Article in English | MEDLINE | ID: mdl-35047759

ABSTRACT

Duchenne muscular dystrophy (DMD) is an X-linked myopathy caused by mutations, in most cases deletions and duplications, in the dystrophin gene. Point mutations account for 13% and stop codon mutations are even rarer. Ataluren was approved for the treatment of DMD caused by nonsense mutations in 2014, and several clinical trials documented its efficacy and safety. However, few real-life experience data is available, especially in pediatric age. We report the case of a 2-year- ambulant child affected by DMD caused by the stop-codon mutation c.10801C > T, p.Gln3601X in exon 76, who was early treated with Ataluren at a dosage of 40 mg/kg/die, and presented a rapid improvement in both muscle strength and cognitive and social skills.


Subject(s)
Codon, Nonsense , Muscular Dystrophy, Duchenne , Child , Child, Preschool , Dystrophin/genetics , Exons , Humans , Male , Muscular Dystrophy, Duchenne/drug therapy , Muscular Dystrophy, Duchenne/genetics , Mutation , Oxadiazoles/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...